Peripheral Arterial Disease Trial, Recruiting (NCT07350499)

Peripheral Arterial Disease Trial, Recruiting NCT07350499 Sponsor: Imperative Care, Inc. Condition: Peripheral Arterial Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07350499 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Arterial Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 18 years of age or older
People who are willing and able to attend follow-up appointments as required by the study schedule
People who are willing and able to sign a written consent form before any study-related information is collected
People who have a planned medical procedure that involves the use of Imperative Care vascular devices, used for their intended purpose

Who may not be able to join:

People who have any health conditions or situations that the Imperative Care device instructions specifically list as reasons not to use those devices
People who have a life expectancy of less than one year
People who the supervising doctor considers unsuitable for a procedure using Imperative Care devices
People who may be unable to complete the required follow-up visits during the study
People enrolled in the peripheral vein (leg or arm vein) part of the study only: those whose imaging shows a blood clot extending more than 2 cm into the large vein that runs through the abdomen (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Steven Abramowitz, MD, Medstar Health Research Institute

Phone: 917-375-4735

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07350499

Sponsor: Imperative Care, Inc.

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Arterial Disease

Trial contact: 917-375-4735

More information: https://clinicaltrials.gov/study/NCT07350499

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 18 years of age or older
People who are willing and able to attend follow-up appointments as required by the study schedule
People who are willing and able to sign a written consent form before any study-related information is collected
People who have a planned medical procedure that involves the use of Imperative Care vascular devices, used for their intended purpose

Who may not be able to join:

People who have any health conditions or situations that the Imperative Care device instructions specifically list as reasons not to use those devices
People who have a life expectancy of less than one year
People who the supervising doctor considers unsuitable for a procedure using Imperative Care devices
People who may be unable to complete the required follow-up visits during the study
People enrolled in the peripheral vein (leg or arm vein) part of the study only: those whose imaging shows a blood clot extending more than 2 cm into the large vein that runs through the abdomen (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Imperative Care, Inc.

Registry

ClinicalTrials.gov

Start date

13 February 2026

Est. completion

1 March 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Peripheral Arterial Cohort; Peripheral Venous Cohort; Pulmonary Embolism (PE) Cohort

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov